Schattauer 出版社
期刊
会议
图书
作者:Allison Keshishian , Melissa Hamilton ...
来源:[J].Thromb Haemost(IF 6.094), 2017, Vol.117 (6), pp.1072-1082Schattauer 出版社
摘要:The ARISTOTLE trial showed a risk reduction of stroke/systemic embolism (SE) and major bleeding in non-valvular atrial fibrillation (NVAF) patients treated with apixaban compared to warfarin. This retrospective study used four large US claims databases (MarketScan, PharMetri...
作者:Allison Keshishian , Shital Kamble ...
来源:[J].Thromb Haemost(IF 6.094), 2016, Vol.116 (5), pp.975-986Schattauer 出版社
摘要:In addition to warfarin, there are four non-vitamin K antagonist oral anticoagulants (NOACs) available for stroke prevention in non valvular atrial fibrillation (NVAF). There are limited data on the comparative risks of major bleeding among newly anticoagulated NVAF patients...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×